Type of alcoholic beverage and risk of myocardial infarction

American Journal of Cardiology

Volumn 83, Issue 1, 1999, Pages 52-57

  Gaziano, J Michael ^a   Hennekens, Charles H ^c   Godfried, Susan L ^c   Sesso, Howard D ^c   Glynn, Robert J ^c   Breslow, Jan L ^b   Buring, Julie E ^c  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT CODING; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; ALCOHOLIC BEVERAGES; BEER; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK; RISK FACTORS; WINE;

EID: 0032948332     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00782-6     Document Type: Article

References (40)

1. Hennekens C.H. Alcohol. Kaplan N.M., Stamler J. Prevention of coronary heart disease practical management of the risk factors . 1983;130-138 WB Saunders, Philadelphia.
2. Moore R.D., Pearson T. Moderate alcohol consumption and coronary artery disease a review . Medicine. 65:1986;242-267.
3. Maclure M. Demonstration of deductive meta-analysis ethanol intake and risk of myocardial infarction . Epidemiol Rev. 15:1993;328-351.
4. Gaziano J.M., Godfried S., Hennekens C.H. Alcohol and coronary heart disease. Trends Cardiovasc Med. 6:1996;175-178.
5. Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenburgh M., Willett W., Hennekens C.H. Moderate alcohol intake increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 329:1993;1829-1834.
6. Alcohol use and mortality from coronary heart disease the role of high-density lipoprotein cholesterol . Ann Intern Med. 116:1992;881-887.
7. Langer R.D., Criqui M.H., Reed D.M. Lipoproteins and blood pressure as biological pathways for the effect of moderate alcohol consumption on coronary heart disease. Circulation. 85:1992;910-915.
8. Glueck C.J., Hogg E., Allen C., Gartside P.S. Effects of alcohol ingestion on lipids and lipoproteins in normal men isocaloric metabolic studies . Am J Clin Nutr. 33:1980;2287-2293.
9. Hartung G.H., Foreyt J.P., Mitchell R.E., Mitchell J.G., Reeves R.S., Gotto A.M. Jr. Effect of alcohol intake on high-density lipoprotein cholesterol levels in runners and inactive men. JAMA. 249:1983;747-750.
10. Rubin R., Rand M.L. Alcohol and platelet function. Alcohol Clin Exp Res. 18:1994;105-110.
11. Renaud S.C., Beswick A.D., Fehily A.M., Sharp D.S., Elwood P.C. Alcohol and platelet aggregation the Caerphilly Prospective Heart Disease Study . Am J Clin Nutr. 55:1992;1012-1017.
12. Ridker P.M., Vaughan D.E., Stampfer M.J., Glynn R.J., Hennekens C.H. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 272:1994;929-933.
13. Frankel E.N., Kanner J., German J.B., Parks E., Kinsella J.E. Inhibition in vitro of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341:1993;454-457.
14. Siemann E.H., Creasy L.L. Concentration of the phytoalexin resveratrol in wine. Am J Enol Viticulture. 43:1992;1-4.
15. Criqui M.H., Ringel B.L. Does diet or alcohol explain the French paradox? Lancet. 344:1994;1719-1723.
16. Rimm E.B., Giovannucci E.L., Willett W.C., Colditz G.A., Ascherio A., Rosner B., Stampfer M.J. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 338:1991;464-468.
17. Hennekens C.H., Willett W., Rosner B., Cole D.S., Mayrent S.L. Effects of beer, wine, and liquor in coronary deaths. JAMA. 242:1979;1973-1974.
18. Rosenberg L., Slone D., Shapiro S., Kaufman D.W., Miettinen O.S., Stolley P.D. Alcoholic beverages and myocardial infarction in young women. Am J Public Health. 71:1981;82-85.
19. Kaufman D.W., Rosenberg L., Helmrich S.P., Shapiro S. Alcoholic beverages and myocardial infarction in young men. Am J Epidemiol. 121:1985;548-554.
20. Stampfer M.J., Colditz G.A., Willett W.C., Speizer F.E., Hennekens C.H. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 319:1988;267-273.
21. Klatsky A.L., Armstrong M.A., Friedman G.D. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol. 66:1990;1237-1242.
22. Gronbaek M., Deis A., Sorensen T.I.A., Becker U., Schnohr P., Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. Br Med J. 310:1995;1165-1169.
23. Yano K., Rhoades G.G., Kagan A. Coffee, alcohol, and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med. 297:1977;405-409.
24. Kittner S.J., Garcia P.M., Costas R.J., Cruz V.M., Abbott R.D., Havlik R.J. Alcohol and coronary heart disease in Puerto Rico. Am J Epidemiol. 117:1983;538-550.
25. Salonen J.T., Puska P., Nissinen A. Intake of spirits and beer and risk of myocardial infarction and death-a longitudinal study in Eastern Finland. J Chronic Dis. 36:1983;533-543.
26. Rimm E.B., Klatsky A., Grobbee D., Stampfer M.J. Moderate alcohol consumption and the reduction of coronary heart disease is the reduction due to beer, wine, or spirits . Br Med J. 312:1996;731-736.
27. Haynes S.G., Levine S., Scotch N., Feinleib M., Kannel W.B. The relationship of psychosocial factors to coronary heart disease in the Framingham study. I. Methods and risk factors. Am J Epidemiol. 107:1978;362-383.
28. Willett W.C., Sampson L., Stampfer M.J., Rosner B., Bain C., Witschi J., Hennekens C.H., Speizer F.E. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 122:1985;51-65.
29. Giovannucci E., Colditz G., Stampfer M.J., Rimm E.B., Litin L., Sampson L., Willett W.C. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol. 133:1991;810-817.
30. Lipid Research Clinics population studies data book. vol I. The Prevalence Study. Bethesda, MD: Dept of Health and Human Services, 1980:28-81. (DHHS publication no. (NIH) 80-1537).
31. Warnick G.R., Benderson J., Albers J.J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 28:1982;1379-1388.
32. National Heart and Lung Institute. Manual of laboratory operations: Lipid Research Clinics Program. Vol I. Lipid and Lipoprotein Analysis. Bethesda, MD: National Heart and Lung Institute, 1974; 51-59. (DHEW publication no. (NIH) 75-628).
33. Gidez L.I., Miller G.J., Burstein M., Slagle S., Eder H.A. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res. 23:1982;1206-1223.
34. Schlesselman J.J. Case Control Studies Design, Conduct, Analysis . 1982;Oxford University Press, New York.
35. Kleinbaum D.G., Kupper L.L., Morganstern H. Epidemiologic Research Principles and Quantitative Methods . 1982;Lifetime Learning, Belmont, CA.
36. Klatsky A.L. Epidemiology of coronary heart disease - influence of alcohol. Alcohol Clin Exp Res. 18:1994;88-96.
37. Klatsky A.L., Armstrong M.A. Alcoholic beverage choice and risk of coronary artery disease mortality do red wine drinkers fare best . Am J Cardiol. 71:1993;467-469.
38. Moore R.D., Smith C.R., Kwiterovich P.O., Pearson T.A. Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B. Am J Med. 84:1988;884-890.
39. Boffetta P., Garfinkle L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology. 1:1990;342-348.
40. Blackwelder W.C., Yano K., Rhoads G.G., Kagan A., Gordon T., Palesch Y. Alcohol and mortality. The Honolulu Heart Study. Am J Med. 68:1980;164-169.